Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKesson
McKinsey
Boehringer Ingelheim
AstraZeneca

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR AMBIEN


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Ambien

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00042146 ↗ Behavioral and Pharmacological Treatment for Insomnia Completed National Institute of Mental Health (NIMH) Phase 4 2001-12-01 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (AmbienĀ®), for chronic insomnia.
NCT00042146 ↗ Behavioral and Pharmacological Treatment for Insomnia Completed Laval University Phase 4 2001-12-01 This study will evaluate the long- and short-term effects of cognitive-behavior therapy (CBT), alone and in combination with zolpidem (AmbienĀ®), for chronic insomnia.
NCT00044629 ↗ Combined Behavioral/Pharmacological Therapy for Insomnia Completed National Institute of Mental Health (NIMH) Phase 2 2001-09-01 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
NCT00044629 ↗ Combined Behavioral/Pharmacological Therapy for Insomnia Completed Duke University Phase 2 2001-09-01 This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ambien

Condition Name

Condition Name for Ambien
Intervention Trials
Healthy 9
Insomnia 8
Sleep Initiation and Maintenance Disorders 4
Sleep 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ambien
Intervention Trials
Sleep Initiation and Maintenance Disorders 20
Depression 5
Sleep Wake Disorders 3
Parasomnias 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ambien

Trials by Country

Trials by Country for Ambien
Location Trials
United States 73
Canada 4
India 2
Argentina 1
Germany 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ambien
Location Trials
Pennsylvania 8
California 8
New York 6
Massachusetts 5
Ohio 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ambien

Clinical Trial Phase

Clinical Trial Phase for Ambien
Clinical Trial Phase Trials
Phase 4 18
Phase 3 2
Phase 2/Phase 3 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ambien
Clinical Trial Phase Trials
Completed 40
Unknown status 2
Withdrawn 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ambien

Sponsor Name

Sponsor Name for Ambien
Sponsor Trials
National Institute of Mental Health (NIMH) 6
Sanofi 6
National Institutes of Health (NIH) 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ambien
Sponsor Trials
Other 36
Industry 25
U.S. Fed 14
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Moodys
Merck
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.